5 SIMPLE STATEMENTS ABOUT ABBV-744 CLINICAL TRIAL PHASE 1 RESULTS EXPLAINED

In Section A, members will obtain various doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Extra contributors are going to be enrolled on the identified monotherapy dosign program. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be given as "increase-on" therapy. In Segment C,